EZH2 and ovarian cancer: Also, impaired EZH2 expression in T cells resulted in poor tumor control in ovarian cancer and melanoma, highlighting the important role of Ezh2 in maintaining the survival of effector T cells and T cell polyfunctional cytokine expression as well as the formation of memory precursor T cells [63, 64].